---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "IMS Patient App"
developer_entity: "Meditab Software Inc."
bundle_id: "com.meditab.patientapp"
app_store_id: "1064053341"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-07-22"
report_date: "2026-08-22"
last_verified: "2026-08-22T00:00:00.000Z"
report_version: "40.1.0"
total_reviews: 60
overall_rating: 2
sentiment: "Upset"
sentiment_score: 15
confidence: "medium"
confidence_score: 0.45
top_praise_theme: "Patients appreciate the ability to conduct video televisits with providers without needing to travel"
top_complaint_theme: "Frequent authentication failures and forced sign-outs prevent users from accessing their medical records"
review_sample_size: 25
total_review_count: 25
analyzed_review_count: 25
data_age_days: 12
momentum_velocity: "zombie"
intelligence_version: 3
tags: ["medical", "free", "upset sentiment", "mobile app", "app review", "app analysis", "patients", "healthcare", "providers"]
canonical_url: "https://marlvel.ai/apps/ims-patient-app"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# IMS Patient App Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free
- **Signal**: Rating 1.97 · Sentiment Upset
- **Recent focus**: Frequent authentication failures and forced sign-outs prevent users from accessing their medical records (top complaint) · Patients appreciate the ability to conduct video televisits with providers without needing to travel (top praise)

> **TL;DR:** IMS Patient App is a medical app by Meditab Software Inc., rated 1.97/5 by 60 users, with Upset user sentiment (15/100), available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** IMS Patient App faces Upset user sentiment (1.97/5 from 60 reviews), with users reporting frequent authentication failures and forced sign-outs prevent users from accessing their medical records as the primary concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 1.97/5 (60 reviews) |
| **User Mood** | Upset |
| **Category** | Medical |
| **Developer** | Meditab Software Inc. |
| **Pricing** | Free |
| **Platforms** | iOS |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 12d |

## Metadata & Market Performance
- **Publisher:** Meditab Software Inc.
- **Category:** Medical
- **Target Audience:** Patients of healthcare providers who utilize the Meditab software suite for clinical management.
- **Platforms:** iOS
- **Version Reviewed:** 40.1.0
- **Report Date:** 2026-08-22
- **Signal Count:** 25 reviews analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 1064053341
- **Bundle ID:** com.meditab.patientapp
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-22

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** IMS Patient App is a mobile portal for patients to manage healthcare records, appointments, and virtual visits on iOS.
**Why users hire it:** It removes the administrative friction of manual office check-ins and scheduling for patients of Meditab-integrated clinics.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Clinical Integration Suite:** Access to health records and prescription refills, driving institutional adoption.
- **[Differentiator] Televisit Module:** Enables remote consultations, allowing providers to bill for virtual services.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Auto Check-In Kiosk:** Generates barcodes for physical office check-in, reducing administrative overhead.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

IMS Patient App maintains a 1.97-star rating across 60 total ratings. The lack of updates for over 13 months signals a maintenance-only posture that leaves the patient experience stagnant.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access for patients of participating healthcare providers
- **Analysis:** The app functions as a free utility for patients, with monetization occurring through B2B licensing to healthcare providers.

<!-- section:sentiment -->
## 🔴 User Sentiment (Medium Confidence: 25 of 25 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 1.97/5
- **Platform Split:** iOS 2.0/5 (60 ratings)
- **Overall Sentiment:** Upset

### Top Praises
- **Patients appreciate the ability to conduct video televisits with providers without needing to travel**
- **Barcode check-in functionality at the clinic provides a convenient experience for frequent visitors**

### Top Complaints (Impact Areas)

- **Frequent authentication failures and forced sign-outs prevent users from accessing their medical records**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Integrated televisit and kiosk check-in modules provide a unified clinical workflow

**Growth Levers:**
- Biometric authentication integration would resolve the top requested login frustration


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app remains in a stagnant state with no functional changes, but the competitive assessment has sharpened to highlight the risks of institutional churn and the artificial nature of its market position.

**Overall trend**: Stable
**Compared at**: 2026-08-22

### High-impact changes
- **[Shifted] Monopoly Positioning** (positioning)

### Medium-impact changes
- **[Added] Institutional Churn Risk** (swot)
- **[Removed] Security Concern Removal** (swot)

<!-- section:whats-new -->
## What's New

- **Latest (v40.1.0, 1 years ago):** Maintenance update focused on bug fixes and performance improvements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Ships no feature updates for 13 months.
- Maintains maintenance-only release cadence.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 396 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

IMS Patient App is a medical app that is completely free.
With a 1.97/5 rating from 60 reviews, it faces significant user friction.

<!-- speakable-start -->
> **Bottom Line:** Stabilizing the core authentication and appointment modules would address the technical failures currently driving the 1.97-star rating. Protecting the patient-facing experience is essential to maintaining the B2B licensing value for Meditab-using clinics.
<!-- speakable-end -->

**Best for:** Patients of healthcare providers who utilize the Meditab software suite for clinical management.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Rebuild authentication flow to include biometric support because login failures are the primary driver of negative sentiment -> improve rating baseline
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The outlook for IMS Patient App is declining due to a prolonged lack of feature updates and persistent technical instability. Without a commitment to addressing core authentication and crash issues, the app risks losing its utility as a reliable patient portal for Meditab-using clinics.

- 🔴 The 13-month release gap indicates a lack of active development, which compounds the technical debt visible in authentication failures.
- 🔴 Persistent crashes on the appointments tile erode user trust, leading to lower adoption of the app's core clinical features.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 1.97/5 |
| Total Reviews | 60 |
| Sentiment | Upset (15/100) |
| Confidence | Medium |
| Pricing Model | Free |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **IMS Patient App** (this app) | 1.97/5 | Upset | Meditab Software Inc. |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Meditab Software Inc.

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/ims-patient-app/id1064053341?uo=4)
- **Sources:** App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 25
- **Data Sources:** user reviews, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 12 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/ims-patient-app)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.